Skip to main content

View full-text article in PMC

. 2011 Jul;22(7):1382–1389. doi: 10.1681/ASN.2010111185

Table 2.

Comparison of the change in LVMI, FMD response to hyperemia, FMD response to GTN, AIx, and PWV by treatment groups

	Allopurinol	Placebo	P
Change in LVMI at 9 months (g/m²)	−1.42 (±4.67)	+1.28 (±4.45)	0.036^a
Change in FMD response to hyperemia at 6 months (%)	+1.72 (±2.95)	−0.03 (±2.84)	0.053
Change in FMD response to hyperemia at 9 months (%)	+1.26 (±3.06)	−1.05 (±2.84)	0.009^b
Change in FMD response to GTN at 6 months (%)	−0.29 (±6.16)	−1.91 (±8.38)	0.729
Change in FMD response to GTN at 9 months (%)	−0.50 (±5.87)	−1.06 (±6.65)	0.918
Change in AIx at 6 months (%)	−0.04 (±7.19)	+3.41 (±5.37)	0.048^a
Change in AIx at 9 months (%)	−4.70 (±9.30)	+0.77 (±6.06)	0.015^a
Change in PWV at 6 months (m/s)	−0.06 (±1.52)	−0.56 (±1.52)	0.141
Change in PWV at 9 months (m/s)	−0.39 (±1.13)	+0.20 (±1.28)	0.086

GTN, glyceryl trinitrate.

^aP < 0.05;

^bP < 0.01.